Table 3 Multivariate analysis of factors related with OS, LFS, CIR and NRM.

From: Total body irradiation versus chemotherapy myeloablative conditioning in B-cell acute lymphoblastic leukaemia patients with first complete remission

 

Risk factors

P-value

HR (95% CI)

OS

Donor type (Auto vs. Allo)

0.840

0.818 (0.12–5.81)

 

Maintenance after transplantation (Yes vs. No)

0.057

0.250 (0.06–1.04)

LFS

Maintenance after transplantation (Yes vs. No)

0.017

0.485 (0.27–0.88)

CIR

MRD after 3 cycle chemotherapy (Positive vs. Negative)

0.110

1.635 (0.89–3.01)

 

TBI (Yes vs. No)

0.064

0.555(0.30–1.03)

NRM

TBI (Yes vs. No)

0.072

3.230(0.90–11.60)

 

Maintenance after transplantation (Yes vs. No)

0.026

0.100(0.01–0.76)